PERRIGO (NASDAQ:PRGO)
39.31
+0.14 (0.36%)
| PERRIGO (NASDAQ:PRGO) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $39.17 | 52 Week High | $40.55 | ||
| Open | $38.95 | 52 Week Low | $18.54 | ||
| Day High | $39.44 | P/E | 22.21 | ||
| Day Low | $38.81 | EPS | $1.77 | ||
| Volume | 456,765 | ||||
| More PRGO Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| TASE | 9 | MCO | 4 |
| POT | 4 | BP | 4 |
| YUM | 4 | AGN | 4 |
| MHS | 4 | ADS | 4 |
| AFLYY | 3 | CHT | 3 |
| GALP | 3 | LOG | 3 |
Entities who have mentioned PRGO
- Credit Suisse | View Related Stories »
- UBS | View Related Stories »
- Dividend | View Related Stories »
- Goldman Sachs | View Related Stories »
- Morgan Stanley | View Related Stories »
- Citi | View Related Stories »
- Matrix USA | View Related Stories »
- JPMorgan | View Related Stories »
- Collins Stewart | View Related Stories »
- Scopia Capital | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
- KeyBanc | View Related Stories »
- Trading Radar | View Related Stories »
- HSBC | View Related Stories »
- Vanguard | View Related Stories »
- 13G | View Related Stories »
- Needham & Co | View Related Stories »
- Keefe, Bruyette & Woods | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
- Goldman Sachs Conviction Sell List | View Related Stories »
- Piper Jaffray | View Related Stories »
- Stifel Nicolaus | View Related Stories »
- Barclays | View Related Stories »
- Notable Mergers and Acquisitions | View Related Stories »
- William Blair | View Related Stories »
View All Major News StreetInsider.com Major News for PRGO
- Perrigo Co. (PRGO) Tops Q1 EPS Views, Posts $0.66; Raises FY10 EPS Guidance
- Perrigo (PRGO) Tops Q3 Views; Raises FY10 Outlook
- Perrigo (PRGO) Reports Mixed Q4 Results; Guides FY10 EPS
View All ReportsStreetInsider.com Reports on PRGO
- Perrigo (PRGO) Tops Q3 Views; Raises FY10 Outlook
- Perrigo (PRGO) Decalres $0.0625 Quarterly Dividend; 0.7% Yield
- Perrigo (PRGO) Says Duac Patent Litigation Dismissed
- SunTrust Starts Perrigo (PRGO) at Buy, $41 Price Target
- Perrigo (PRGO) Receives Final FDA Approval for Polyethylene Glycol 3350
View All Press ReleasesCompany Press Releases on PRGO
- Perrigo Company To Present at the Sidoti Emerging Growth Conference
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Perrigo Company to Present at the Credit Suisse 18th Annual Health Care Conference
- Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance
- Perrigo Company Divests Israel Cosmetics Business for 205 Million New Israeli Shekels
StreetInsider Reports on PRGO by Category
View All BlogsBlogs on PRGO
- Perrigo: Worth Holding Onto
- Best Performing Mid and Small Cap Stocks Since 10/9/07 Peak
- Perrigo Smiles at the Future
- Closing Update for Tuesday, August 18: Some Recouping
- Perrigo Company F4Q09 (Qtr End 06/27/09) Earnings Call Transcript
View All FilingsSEC Filings on PRGO
- Form 4 PERRIGO CO For: Nov 17 Filed by: Shah Jatin
- Form 4 PERRIGO CO For: Aug 27 Filed by: JANDERNOA MICHAEL J
- Form 4 PERRIGO CO For: Nov 13 Filed by: Kochan Sharon
- Form 4 PERRIGO CO For: Nov 13 Filed by: Lebel Refael
- Form 4 PERRIGO CO For: Nov 12 Filed by: KINGMA TODD W
Comments on recent PRGO articles
Comments on PRGO
No comments are currently available.
on Apr 1, 2008
at 12:23 AM FREE ZYRTEC-D ON SOCIAL SECURITY
Article: Perrigo (PRGO) to Market Generic Zyrtec-D